Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Japanese guidelines for allergic rhinitis 2020.
Okubo K, Kurono Y, Ichimura K, Enomoto T, Okamoto Y, Kawauchi H, Suzaki H, Fujieda S, Masuyama K; Japanese Society of Allergology. Okubo K, et al. Among authors: masuyama k. Allergol Int. 2020 Jul;69(3):331-345. doi: 10.1016/j.alit.2020.04.001. Epub 2020 May 27. Allergol Int. 2020. PMID: 32473790 Free article. Review.
Complementary and alternative medicine for allergic rhinitis in Japan.
Yonekura S, Okamoto Y, Sakurai D, Sakurai T, Iinuma T, Yamamoto H, Hanazawa T, Horiguchi S, Kurono Y, Honda K, Majima Y, Masuyama K, Takeda N, Fujieda S, Okano M, Ogino S, Okubo K. Yonekura S, et al. Among authors: masuyama k. Allergol Int. 2017 Jul;66(3):425-431. doi: 10.1016/j.alit.2016.10.006. Epub 2016 Nov 21. Allergol Int. 2017. PMID: 27884625 Free article.
Japanese guidelines for allergic rhinitis 2017.
Okubo K, Kurono Y, Ichimura K, Enomoto T, Okamoto Y, Kawauchi H, Suzaki H, Fujieda S, Masuyama K; Japanese Society of Allergology. Okubo K, et al. Among authors: masuyama k. Allergol Int. 2017 Apr;66(2):205-219. doi: 10.1016/j.alit.2016.11.001. Epub 2017 Feb 15. Allergol Int. 2017. PMID: 28214137 Free article. Review.
Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trial.
Fujisawa T, Shimoda T, Masuyama K, Okubo K, Honda K, Okano M, Katsunuma T, Urisu A, Kondo Y, Odajima H, Kurihara K, Nagata M, Taniguchi M, Taniuchi S, Doi S, Matsumoto T, Hashimoto S, Tanaka A, Natsui K, Abe N, Ozaki H. Fujisawa T, et al. Among authors: masuyama k. Allergol Int. 2018 Jul;67(3):347-356. doi: 10.1016/j.alit.2017.11.004. Epub 2017 Dec 7. Allergol Int. 2018. PMID: 29233461 Free article. Clinical Trial.
Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
Gotoh M, Okubo K, Yuta A, Ogawa Y, Nagakura H, Ueyama S, Ueyama T, Kawashima K, Yamamoto M, Fujieda S, Sakashita M, Sakamoto H, Iwasaki N, Mori E, Endo T, Ohta N, Kitazawa H, Okano M, Asako M, Takada M, Terada T, Inaka Y, Yonekura S, Matsuoka T, Kaneko S, Hata H, Hijikata N, Tanaka H, Masuyama K, Okamoto Y. Gotoh M, et al. Among authors: masuyama k. Allergol Int. 2020 Jan;69(1):104-110. doi: 10.1016/j.alit.2019.07.007. Epub 2019 Aug 14. Allergol Int. 2020. PMID: 31421989 Free article. Clinical Trial.
Guiding principles of sublingual immunotherapy for allergic rhinitis in Japanese patients.
Masuyama K, Goto M, Takeno S, Ohta N, Okano M, Kamijo A, Suzuki M, Terada T, Sakurai D, Horiguchi S, Honda K, Matsune S, Yamada T, Sakashita M, Yuta A, Fuchiwaki T, Miyanohara I, Nakayama T, Okamoto Y, Fujieda S. Masuyama K, et al. Auris Nasus Larynx. 2016 Feb;43(1):1-9. doi: 10.1016/j.anl.2015.08.015. Epub 2015 Nov 23. Auris Nasus Larynx. 2016. PMID: 26615715 Review.
195 results